Cargando…
Eradicating Pulmonary Mycobacterium abscessus: The Promise of Dual β-Lactam Therapy
Macrolide resistance has rendered the treatment of Mycobacterium abscessus extremely difficult and is fueling a crisis. Recently, there has been dramatically increased incidence of infections by M abscessus. Select dual β-lactam combinations have shown promising in vitro results. Herein, we present...
Autores principales: | Alahmdi, Bayan, Dousa, Khalid M, Kurz, Sebastian G, Kaufman, Andrew, Bonomo, Robert A, Taimur, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296056/ https://www.ncbi.nlm.nih.gov/pubmed/37383246 http://dx.doi.org/10.1093/ofid/ofad312 |
Ejemplares similares
-
1642. A Novel β-lactamase Inhibitor (Durlobactam, DUR) and β-Lactams Enhance Susceptibility Against Multidrug-Resistant (MDR) Mycobacterium abscessus (Mab)
por: Dousa, Khalid M, et al.
Publicado: (2020) -
1385. Mechanism-Based, In Vitro Inhibition of Mycobacterium abscessus: Assessing β-Lactam Therapy
por: Dousa, Khalid M, et al.
Publicado: (2019) -
786. Ceftaroline and Avibactam? Is This a Potential Combination for Mycobacterium abscessus Infection?
por: Dousa, Khalid M, et al.
Publicado: (2018) -
A 40-Year-Old Female With Mycobacterium abscessus Successfully Treated With a Dual Beta-Lactam Combination
por: Moguillansky, Natalia, et al.
Publicado: (2023) -
Eradication of Mycobacterium abscessus Pulmonary Infection in a Child With Idiopathic Bronchiectasis
por: Anisowicz, Sarah K., et al.
Publicado: (2016)